Celltrion unit pays $330 million for Eli Lilly production facility, filing shows
PositiveFinancial Markets

Celltrion has made a significant move by acquiring a production facility from Eli Lilly for $330 million. This acquisition is important as it enhances Celltrion's manufacturing capabilities and positions the company for growth in the biopharmaceutical sector. With this facility, Celltrion aims to expand its production capacity and meet the increasing demand for its products, which could lead to more innovation and job creation in the industry.
— Curated by the World Pulse Now AI Editorial System